Search research articles
Contact Us
Filters
Showing results (21-30 of 141) with videos related to
Page
of 15
Sort By:
Frontiers in Veterinary Science
|
April 11, 2022
Determining Candidate Hypobaric Hypoxia Profiles for Humane Killing of Laboratory Mice
Jasmine M Clarkson, Dorothy E F McKeegan, Julian Sparrey, et al.
Experimental Hematology & Oncology
|
June 30, 2015
Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma
Francesco Pisani, Rosa Sciuto, Maria Laura Dessanti, et al.
Blood Reviews
|
November 24, 2020
Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?
Giulia Regazzo, Francesco Marchesi, Manuela Spagnuolo, et al.
Chemotherapy
|
November 21, 2018
Isavuconazole: Case Report and Pharmacokinetic Considerations
Francesco Marchesi, Corrado Girmenia, Bianca Maria Goffredo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial
Giorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline Chemotherapy
Pierantonio Menna, Vito Calabrese, Grazia Armento, et al.
Journal of Fungi (Basel, Switzerland)
|
February 25, 2022
When Viruses Meet Fungi: Tackling the Enemies in Hematology
Alessandro Busca, Francesco Marchesi, Chiara Cattaneo, et al.
Veterinary Immunology and Immunopathology
|
November 20, 2016
Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies
Elspeth M Waugh, Alice Gallagher, Hayley Haining, et al.
Integrative Cancer Therapies
|
December 24, 2019
The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma
Marta Maschio, Alessia Zarabla, Andrea Maialetti, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 141) with videos related to
Sort By:
Page
of 15
Frontiers in Veterinary Science
|
April 11, 2022
Determining Candidate Hypobaric Hypoxia Profiles for Humane Killing of Laboratory Mice
Jasmine M Clarkson, Dorothy E F McKeegan, Julian Sparrey, et al.
Experimental Hematology & Oncology
|
June 30, 2015
Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma
Francesco Pisani, Rosa Sciuto, Maria Laura Dessanti, et al.
Blood Reviews
|
November 24, 2020
Diffuse large B-cell lymphoma: Time to focus on circulating blood nucleic acids?
Giulia Regazzo, Francesco Marchesi, Manuela Spagnuolo, et al.
Chemotherapy
|
November 21, 2018
Isavuconazole: Case Report and Pharmacokinetic Considerations
Francesco Marchesi, Corrado Girmenia, Bianca Maria Goffredo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines
Pierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial
Giorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline Chemotherapy
Pierantonio Menna, Vito Calabrese, Grazia Armento, et al.
Journal of Fungi (Basel, Switzerland)
|
February 25, 2022
When Viruses Meet Fungi: Tackling the Enemies in Hematology
Alessandro Busca, Francesco Marchesi, Chiara Cattaneo, et al.
Veterinary Immunology and Immunopathology
|
November 20, 2016
Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies
Elspeth M Waugh, Alice Gallagher, Hayley Haining, et al.
Integrative Cancer Therapies
|
December 24, 2019
The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma
Marta Maschio, Alessia Zarabla, Andrea Maialetti, et al.
Page
of 15